The current valuation score of Kiora Pharmaceuticals Inc is 8.72, ranking 93 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.99, which is -539.02% below the recent high of 4.34 and -11.21% above the recent low of -1.10.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.